Teva Sets the Trend as More Generics Companies Motion to Merge

Wednesday, August 5, 2015

Source: Bloomberg

The $40.5 billion merger that’s transforming the generics industry is the biggest yet in a series of deals by drugmakers adjusting to a market that has fewer buyers.

View All News »